Showing results (231-240 of 272) with videos related to
Sort By:
Pageof 28
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.Health Promotion International|November 29, 2008
Schools for health, education and development: a call for actionKwok-Cho Tang, Don Nutbeam, Carmen Aldinger, et al.Annals of the Rheumatic Diseases|January 28, 2025
EULAR recommendations for the treatment of systemic sclerosis: 2023 updateFrancesco Del Galdo, Alain Lescoat, Philip G Conaghan, et al.Msystems|May 31, 2024
SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA's GenomeTrakr networkRuth E Timme, Jacquelina Woods, Jessica L Jones, et al.Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.Pageof 28